Home Healthcare Pharmaceuticals Drug Delivery Technologies Market

Drug Delivery Technologies Market Size, Share & Trends Analysis Report By Technology (Targeted Drug Delivery, Sustained Release Technology, Controlled Release Drug Delivery, Polymeric Drug Delivery, Others), By Route of Administration (Oral, Nasal, Parenteral, Topical), By Application (Oncology, Respiratory Diseases, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Drug Delivery Technologies Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Targeted Drug Delivery
    2. Sustained Release Technology
    3. Controlled Release Drug Delivery
    4. Polymeric Drug Delivery
    5. Others
  2. Drug Delivery Technologies Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Nasal
    3. Parenteral
    4. Topical
  3. Drug Delivery Technologies Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Respiratory Diseases
    3. Cardiovascular Diseases
    4. Autoimmune Diseases
    5. Central Nervous System Disorders
    6. Others
  4. Drug Delivery Technologies Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Diagnostic Centers
    4. Others
  5. Regional Drug Delivery Technologies Market
    1. North America
      1. North America Drug Delivery Technologies Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
      2. North America Drug Delivery Technologies Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Nasal
        3. Parenteral
        4. Topical
      3. North America Drug Delivery Technologies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Respiratory Diseases
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Central Nervous System Disorders
        6. Others
      4. North America Drug Delivery Technologies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Others
      5. U.S.
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      6. Canada
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
    2. Europe
      1. Europe Drug Delivery Technologies Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
      2. Europe Drug Delivery Technologies Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Nasal
        3. Parenteral
        4. Topical
      3. Europe Drug Delivery Technologies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Respiratory Diseases
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Central Nervous System Disorders
        6. Others
      4. Europe Drug Delivery Technologies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Others
      5. U.K.
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      6. Germany
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      7. France
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      8. Spain
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      9. Italy
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      10. Russia
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      11. Nordic
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      12. Benelux
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      13. Rest of Europe
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
    3. APAC
      1. APAC Drug Delivery Technologies Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
      2. APAC Drug Delivery Technologies Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Nasal
        3. Parenteral
        4. Topical
      3. APAC Drug Delivery Technologies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Respiratory Diseases
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Central Nervous System Disorders
        6. Others
      4. APAC Drug Delivery Technologies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Others
      5. China
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      6. Korea
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      7. Japan
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      8. India
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      9. Australia
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      10. Taiwan
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      11. South East Asia
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      12. Rest of Asia-Pacific
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
    4. Middle East and Africa
      1. Middle East and Africa Drug Delivery Technologies Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
      2. Middle East and Africa Drug Delivery Technologies Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Nasal
        3. Parenteral
        4. Topical
      3. Middle East and Africa Drug Delivery Technologies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Respiratory Diseases
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Central Nervous System Disorders
        6. Others
      4. Middle East and Africa Drug Delivery Technologies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Others
      5. UAE
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      6. Turkey
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      7. Saudi Arabia
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      8. South Africa
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      9. Egypt
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      10. Nigeria
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      11. Rest of MEA
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
    5. LATAM
      1. LATAM Drug Delivery Technologies Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
      2. LATAM Drug Delivery Technologies Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Nasal
        3. Parenteral
        4. Topical
      3. LATAM Drug Delivery Technologies Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Respiratory Diseases
        3. Cardiovascular Diseases
        4. Autoimmune Diseases
        5. Central Nervous System Disorders
        6. Others
      4. LATAM Drug Delivery Technologies Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Others
      5. Brazil
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      6. Mexico
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      7. Argentina
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      8. Chile
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      9. Colombia
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
      10. Rest of LATAM
        1. Targeted Drug Delivery
        2. Sustained Release Technology
        3. Controlled Release Drug Delivery
        4. Polymeric Drug Delivery
        5. Others
        6. Oral
        7. Nasal
        8. Parenteral
        9. Topical
        10. Oncology
        11. Respiratory Diseases
        12. Cardiovascular Diseases
        13. Autoimmune Diseases
        14. Central Nervous System Disorders
        15. Others
        16. Hospitals
        17. Ambulatory Surgical Centers
        18. Diagnostic Centers
        19. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.